d-serine levels in Alzheimer's disease: implications for novel biomarker development

Alzheimer's disease (AD) is a severe neurodegenerative disorder still in search of effective methods of diagnosis. Altered levels of the NMDA receptor co-agonist, d-serine, have been associated with neurological disorders, including schizophrenia and epilepsy. However, whether d-serine levels a...

Descripción completa

Detalles Bibliográficos
Autores principales: Madeira, C, Lourenco, M V, Vargas-Lopes, C, Suemoto, C K, Brandão, C O, Reis, T, Leite, R E P, Laks, J, Jacob-Filho, W, Pasqualucci, C A, Grinberg, L T, Ferreira, S T, Panizzutti, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471283/
https://www.ncbi.nlm.nih.gov/pubmed/25942042
http://dx.doi.org/10.1038/tp.2015.52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471283/
https://www.ncbi.nlm.nih.gov/pubmed/25942042
http://dx.doi.org/10.1038/tp.2015.52

Ejemplares similares